Deferasirox Tablets

Deferasirox Tablets
SPL v6
SPL
SPL Set ID fcd2ffe2-c8ba-400b-b7f9-e0e4b3510b98
Route
ORAL
Published
Effective Date 2023-09-21
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Deferasirox (90 mg)
Inactive Ingredients
Croscarmellose Sodium Hypromellose 2910 (6 Mpa.s) Magnesium Stearate Microcrystalline Cellulose Poloxamer 407 Polyethylene Glycol 8000 Povidone K30 Silicon Dioxide Talc Titanium Dioxide D&c Red No. 27 Fd&c Blue No. 2 Ferric Oxide Yellow

Identifiers & Packaging

Pill Appearance
Imprint: 1276 Shape: oval Color: white Color: blue Size: 11 mm Size: 17 mm Size: 14 mm Score: 1
Marketing Status
ANDA Active Since 2020-06-16

Description

NDC 70771-1471-3 Deferasirox tablets, 90 mg 30 Tablets Rx only NDC 70771-1472-3 Deferasirox tablets, 180 mg 30 Tablets Rx only NDC 70771-1473-3 Deferasirox tablets, 360 mg 30 Tablets Rx only


Medication Information

Description

NDC 70771-1471-3 Deferasirox tablets, 90 mg 30 Tablets Rx only NDC 70771-1472-3 Deferasirox tablets, 180 mg 30 Tablets Rx only NDC 70771-1473-3 Deferasirox tablets, 360 mg 30 Tablets Rx only

Package Label.principal Display Panel

NDC 70771-1471-3

Deferasirox tablets, 90 mg

30 Tablets

Rx only

NDC 70771-1472-3

Deferasirox tablets, 180 mg

30 Tablets

Rx only

NDC 70771-1473-3

Deferasirox tablets, 360 mg

30 Tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1471-3

Deferasirox tablets, 90 mg

30 Tablets

Rx only

NDC 70771-1472-3

Deferasirox tablets, 180 mg

30 Tablets

Rx only

NDC 70771-1473-3

Deferasirox tablets, 360 mg

30 Tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)